STAT

Experts call for reversing the decision to deny the Ebola vaccine to pregnant women

The vaccine "will give pregnant women, and the children they are carrying, a chance to live," the experts wrote. "Without it, most of the pregnant women infected with Ebola, and…
Nurses working with the World Health Organization prepare to administer vaccines in Mbandaka during the launch of the Ebola vaccination campaign in May in the Democratic Republic of Congo.

The exclusion of pregnant and lactating women from an effort to vaccinate people exposed to the Ebola virus in the current outbreak is wrong, indefensible, and should be reversed, three public health experts wrote Monday in an opinion article published in STAT.

The Johns Hopkins University experts argued it is unfair to deny pregnant and lactating women the experimental vaccine if they wish to take it, given the great risk Ebola poses to them. The fatality rate is 80 percent or higher for pregnant women who contract Ebola, and nearly all survivors miscarry.

The decision was made by the Democratic Republic of the Congo’s health ministry, based on the advice of two expert panels that advise it on use of experimental Ebola therapies and vaccines. But the DRC’s position echoes the recommendations of the World Health Organization on how to use Merck’s still-unlicensed Ebola vaccine.

“The … vaccine will give pregnant women, and the children they are carrying, a chance to live. Without it, most of the pregnant women infected with Ebola, and almost all of their infants, will die,” wrote Ruth Faden, Ruth.

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Amylyx Pulling Its ALS Drug, GLP-1 Drugs For Parkinson’s, And More
Amylyx Pharmaceuticals will take its ALS drug Relyvrio off the market in the U.S. and Canada, ending a multi-year saga for patients with the rare neurodegenerative disease.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An OptumRx Contract, 340B Dispute Resolution, And More
Cardinal Health announced its pharmaceutical distribution contracts with UnitedHealth's OptumRx unit will not be renewed after they expire in June.
STAT1 min read
USDA Faulted For Disclosing Scant Information About Outbreaks Of H5N1 Avian Flu In Cattle
With 28 herds in eight states infected with H5N1 bird flu, scientists are calling on the U.S. to release more data to help them assess the risk.

Related Books & Audiobooks